Articles

Articles

Open AccessReview

Strategic Engineering of Lipid Drug Carriers for the Treatment of Cancer

Shuyao Lang, Yunqing Li, Yi Kong, Youhai H. Chen

2025, 4(4): 100020. doi: 10.53941/ijddp.2025.100020

11 Downloaded
79 Viewed
Download PDF
Open AccessReview
Targeting Cancer Drug-Tolerant Persister Cells in Minimal Residual Disease

Wei Zhang, Sorayut Chattrakarn, Fuhui Chen, Haobin Chai, Mariana Maranga, Jingwei Zhang

2025, 4(2): 100011. doi: 10.53941/ijddp.2025.100011

72 Downloaded
128 Viewed
Download PDF
Open AccessReview
Inhibiting the Extracellular Signal-regulated Kinase 1/2 (ERK1/2) Cascade in Cancer and the Heart: for Better or Worse, in Sickness and Health?

Angela Clerk, Shona U Amadi, Samuel J Smith, Peter H Sugden

2024, 3(2): 100006. doi: 10.53941/ijddp.2024.100006

11 Downloaded
51 Viewed
1 Cited
Download PDF
Open AccessReview
Development of Proteasome Inhibitors for Cancer Therapy

Xu Chen, Xuan Wu, Linyan Li, Xiaoming Zhu

2024, 3(1): 100004. doi: 10.53941/ijddp.2024.100004

25 Downloaded
87 Viewed
Download PDF
Open AccessReview
Recent Clinical Successes in Liposomal Nanomedicines

Wenjie Gu, Gavin P. Andrews, Yiwei Tian

2023, 2(1): 52-59. doi: 10.53941/ijddp.0201009

14 Downloaded
46 Viewed
8 Cited
Download PDF